The regulatory T cell effector soluble fibrinogen-like protein 2 induces tubular epithelial cell apoptosis in renal transplantation

Experimental Biology and Medicine

Volumn 239, Issue 2, 2014, Pages 193-201

  Zhao, Zitong ^a,b   Yang, Cheng ^a,b   Wang, Lingyan ^a   Li, Long ^a,b   Zhao, Tian ^a,b   Hu, Linkun ^c   Rong, Ruiming ^a,b   Xu, Ming ^a,b   Zhu, Tongyu ^a,b  

^a FUDAN UNIVERSITY   (China)

^b Shanghai Key Laboratory of Organ Transplantation   (China)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

apoptosis; regulatory T cells; renal transplantation; Soluble fibrinogen like protein 2; tubular epithelial cells

Indexed keywords

APOPTOSIS; REGULATORY T CELLS; RENAL TRANSPLANTATION; SOLUBLE FIBRINOGEN-LIKE PROTEIN 2; TUBULAR EPITHELIAL CELLS;

ADULT; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; FIBRINOGEN; GENE EXPRESSION PROFILING; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MALE; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84893934887     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213514921     Document Type: Article

References (42)

1. Ingulli E.Mechanism of cellular rejection in transplantation.Pediatr Nephrol. 2010;25:61-74.
2. Du C,Guan Q,Yin Z,Masterson M,Zhong R,Jevnikar AM.Renal tubular epithelial cell apoptosis by Fas-FasL-dependent self-injury can augment renal allograft injury.Transplant Proc. 2003;35:2481-2.
3. Wang S,Zhang ZX,Yin Z,Liu W,Garcia B,Huang X,Acott P,Jevnikar AM.Anti-IL-2 receptor antibody decreases cytokine-induced apoptosis of human renal tubular epithelial cells (TEC).Nephrol Dial Transplant. 2011;26:2144-53.
4. Nguan CY,Du C.Renal tubular epithelial cells as immunoregulatory cells in renal allograft rejection.Transplant Rev (Orlando). 2009;23:129-38.
5. Havasi A,Borkan SC.Apoptosis and acute kidney injury.Kidney Int. 2011;80:29-40.
6. Oberbauer R,Rohrmoser M,Regele H,Muhlbacher F,Mayer G.Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function.J Am Soc Nephrol. 1999;10:2006-13.
7. Estaquier J,Vallette F,Vayssiere JL,Mignotte B.The mitochondrial pathways of apoptosis.Adv Exp Med Biol. 2012;942:157-83.
8. Wei Y,Fan T,Yu M.Inhibitor of apoptosis proteins and apoptosis.Acta Biochim Biophys Sin (Shanghai). 2008;40:278-88.
9. Koyama T,Hall LR,Haser WG,Tonegawa S,Saito H.Structure of a cytotoxic T-lymphocyte-specific gene shows a strong homology to fibrinogen beta and gamma chains.Proc Natl Acad Sci USA. 1987;84:1609-13.
10. Liu H,Yang PS,Zhu T,Manuel J,Zhang J,He W,Shalev I,Zhang L,Cybulsky MI,Grant DR,Phillips MJ,Levy GA.Characterization of fibrinogen-like protein 2 (FGL2): Monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2.Int J Biochem Cell Biol. 2013;45:408-18.
11. Herman AE,Freeman GJ,Mathis D,Benoist C.CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion.J Exp Med. 2004;199:1479-89.
12. Fontenot JD,Rasmussen JP,Gavin MA,Rudensky AY.A function for interleukin 2 in Foxp3-expressing regulatory T cells.Nat Immunol. 2005;6:1142-51.
13. Williams LM,Rudensky AY.Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3.Nat Immunol. 2007;8:277-84.
14. Shevach EM.Mechanisms of foxp3+ T regulatory cell-mediated suppression.Immunity. 2009;30:636-45.
15. Selzner N,Liu H,Boehnert MU,Adeyi OA,Shalev I,Bartczak AM,Xue-Zhong M,Manuel J,Rotstein OD,McGilvray ID,Grant DR,Phillips MJ,Levy GA,Selzner M.FGL2/fibroleukin mediates hepatic reperfusion injury by induction of sinusoidal endothelial cell and hepatocyte apoptosis in mice.J Hepatol. 2012;56:153-9.
16. Shalev I,Liu H,Koscik C,Bartczak A,Javadi M,Wong KM,Maknojia A,He W,Liu MF,Diao J,Winter E,Manuel J,McCarthy D,Cattral M,Gommerman J,Clark DA,Phillips MJ,Gorczynski RR,Zhang L,Downey G,Grant D,Cybulsky MI,Levy G.Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis.J Immunol. 2008;180:249-60.
17. Zhao Z,Yang C,Tang Q,Zhao T,Jia Y,Ma Z,Rong R,Xu M,Zhu T.Serum level of soluble fibrinogen-like protein 2 in renal allograft recipients with acute rejection: a preliminary study.Transplant Proc. 2012;44:2982-5.
18. Zhao Z, Wang L, Yang C, Zhao T, Li L, Hu L, Wu D, Rong R, Xu M, Zhu T. Soluble FGL2 induced by tumor necrosis factor-alpha and interferon-gamma in CD4 T cells through MAPK pathway in human renal allograft acute rejection. J Surg Res 2013;184:1114-22.
19. Solez K,Colvin RB,Racusen LC,Haas M,Sis B,Mengel M,Halloran PF,Baldwin W,Banfi G,Collins AB,Cosio F,David DS,Drachenberg C,Einecke G,Fogo AB,Gibson IW,Glotz D,Iskandar SS,Kraus E,Lerut E,Mannon RB,Mihatsch M,Nankivell BJ,Nickeleit V,Papadimitriou JC,Randhawa P,Regele H,Renaudin K,Roberts I,Seron D,Smith RN,Valente M.Banff 07 classification of renal allograft pathology: Updates and future directions.Am J Transplant. 2008;8:753-60.
20. Zhao T,Yang C,Xue Y,Qiu YY,Hu L,Qiu Y,Wang X,Yang B,Rong R,Xu M,Zhu T.Impact of basiliximab on the proportion of regulatory T cells and their subsets early after renal transplantation: A preliminary report.Transplant Proc. 2012;44:175-8.
21. Guan Q,Nguan CY,Du C.Expression of transforming growth factor-beta1 limits renal ischemia-reperfusion injury.Transplantation. 2010;89:1320-7.
22. Cornelissen M,Philippe J,De Sitter S,De Ridder L.Annexin V expression in apoptotic peripheral blood lymphocytes: An electron microscopic evaluation.Apoptosis. 2002;7:41-7.
23. Wood KJ.Regulatory T cells in transplantation.Transplant Proc. 2011;43:2135-6.
24. Sakaguchi S,Yamaguchi T,Nomura T,Ono M.Regulatory T cells and immune tolerance.Cell. 2008;133:775-87.
25. Aquino-Dias EC,Joelsons G,da Silva DM,Berdichevski RH,Ribeiro AR,Veronese FJ,Goncalves LF,Manfro RC.Non-invasive diagnosis of acute rejection in kidney transplants with delayed graft function.Kidney Int. 2008;73:877-84.
26. Taflin C,Nochy D,Hill G,Frouget T,Rioux N,Verine J,Bruneval P,Glotz D.Regulatory T cells in kidney allograft infiltrates correlate with initial inflammation and graft function.Transplantation. 2010;89:194-9.
27. Shalev I,Wong KM,Foerster K,Zhu Y,Chan C,Maknojia A,Zhang J,Ma XZ,Yang XC,Gao JF,Liu H,Selzner N,Clark DA,Adeyi O,Phillips MJ,Gorczynski RR,Grant D,McGilvray I,Levy G.The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis.Hepatology. 2009;49:387-97.
28. Xie L,Ichimaru N,Morita M,Chen J,Zhu P,Wang J,Urbanellis P,Shalev I,Nagao S,Sugioka A,Zhong L,Nonomura N,Takahara S,Levy GA,Li XK.Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance.Liver Transpl. 2012;18:444-54.
29. Foerster K,Helmy A,Zhu Y,Khattar R,Adeyi OA,Wong KM,Shalev I,Clark DA,Wong PY,Heathcote EJ,Phillips MJ,Grant DR,Renner EL,Levy GA,Selzner N.The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infection.J Hepatol. 2010;53:608-15.
30. Wong RS.Apoptosis in cancer: From pathogenesis to treatment.J Exp Clin Cancer Res. 2011;30:87-87.
31. Chong ZZ,Kang JQ,Maiese K.Essential cellular regulatory elements of oxidative stress in early and late phases of apoptosis in the central nervous system.Antioxid Redox Signal. 2004;6:277-87.
32. Daniel B,DeCoster MA.Quantification of sPLA2-induced early and late apoptosis changes in neuronal cell cultures using combined TUNEL and DAPI staining.Brain Res Brain Res Protoc. 2004;13:144-50.
33. Rieger AM,Hall BE,Luong le T,Schang LM,Barreda DR.Conventional apoptosis assays using propidium iodide generate a significant number of false positives that prevent accurate assessment of cell death.J Immunol Methods. 2010;358:81-92.
34. Favaloro B,Allocati N,Graziano V,Di Ilio C,De Laurenzi V.Role of apoptosis in disease.Aging (Albany NY). 2012;4:330-49.
35. Kaushal GP.Role of caspases in renal tubular epithelial cell injury.Semin Nephrol. 2003;23:425-31.
36. Gong YN,Shao F.Sensing bacterial infections by NAIP receptors in NLRC4 inflammasome activation.Protein Cell. 2012;3:98-105.
37. Humke EW,Shriver SK,Starovasnik MA,Fairbrother WJ,Dixit VM.ICEBERG: A novel inhibitor of interleukin-1beta generation.Cell. 2000;103:99-111.
38. Ulukaya E,Acilan C,Yilmaz Y.Apoptosis: Why and how does it occur in biology?.Cell Biochem Funct. 2011;29:468-80.
39. Sun XF,Zhang H.NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases.Histol Histopathol. 2007;22:1387-98.
40. Lieberthal W,Koh JS,Levine JS.Necrosis and apoptosis in acute renal failure.Semin Nephrol. 1998;18:505-18.
41. Lieberthal W,Levine JS.Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury.Am J Physiol. 1996;271:F477-88.
42. Chan CW,Kay LS,Khadaroo RG,Chan MW,Lakatoo S,Young KJ,Zhang L,Gorczynski RM,Cattral M,Rotstein O,Levy GA.Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: Suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells.J Immunol. 2003;170:4036-44.